PGR and metastatic malignant neoplasm in the lymph nodes: 46 studies including 24 microRNAs and 15 lncRNAs were included in analyses of the relationship between ncRNA and clinicopathological features (Supplementary Table 3), such as age, lymph node metastasis (LNM), tumor size, estrogen receptor (ER), progesterone receptor (PR), human epidermalgrowth factor receptor-2 (HER2), and menopausal factors (Table 2).